Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Buy
61
PHIN Quote, Financials, Valuation and Earnings
Last price:
$69.39
Seasonality move
:
1.99%
Day range:
$69.06 - $70.74
52-week range:
$36.25 - $70.98
Dividend yield:
1.56%
P/E ratio:
31.30x
P/S ratio:
0.83x
P/B ratio:
1.68x
Volume:
298.5K
Avg. volume:
421.1K
1-year change:
35.37%
Market cap:
$2.7B
Revenue:
$3.4B
EPS (TTM):
$2.22
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | $3.2B | $3.3B | $3.5B | $3.4B | |
| Revenue Growth (YoY) | -- | 212.09% | 3.75% | 4.54% | -2.77% | |
| Cost of Revenues | $859M | $2.6B | $2.6B | $2.8B | $2.7B | |
| Gross Profit | $175M | $675M | $722M | $692M | $726M | |
| Gross Profit Margin | 16.93% | 20.92% | 21.57% | 19.77% | 21.33% | |
| R&D Expenses | $46M | $132M | $104M | $108M | $112M | |
| Selling, General & Admin | $147M | $460M | $407M | $413M | $442M | |
| Other Inc / (Exp) | -$125M | -$69M | -$6M | -$87M | -$48M | |
| Operating Expenses | $147M | $460M | $407M | $316M | $441M | |
| Operating Income | $28M | $215M | $315M | $376M | $285M | |
| Net Interest Expenses | $16M | $34M | $28M | $56M | $99M | |
| EBT. Incl. Unusual Items | -$105M | $186M | $347M | $206M | $187M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $19M | $33M | $85M | $104M | $108M | |
| Net Income to Company | -$124M | $153M | $262M | $102M | $79M | |
| Minority Interest in Earnings | -- | $1M | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$124M | $153M | $262M | $102M | $79M | |
| Basic EPS (Cont. Ops) | -$2.64 | $3.23 | $5.57 | $2.17 | $1.80 | |
| Diluted EPS (Cont. Ops) | -$2.64 | $3.23 | $5.57 | $2.17 | $1.76 | |
| Weighted Average Basic Share | $47M | $47M | $47M | $46.9M | $44M | |
| Weighted Average Diluted Share | $47M | $47M | $47M | $47M | $44.8M | |
| EBITDA | $90M | $419M | $485M | $547M | $445M | |
| EBIT | $28M | $215M | $315M | $376M | $285M | |
| Revenue (Reported) | $1B | $3.2B | $3.3B | $3.5B | $3.4B | |
| Operating Income (Reported) | $28M | $215M | $315M | $376M | $285M | |
| Operating Income (Adjusted) | $28M | $215M | $315M | $376M | $285M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $859M | $896M | $839M | $908M | |
| Revenue Growth (YoY) | -- | -- | 4.31% | -6.36% | 8.22% | |
| Cost of Revenues | -- | $661M | $726M | $659M | $716M | |
| Gross Profit | -- | $198M | $170M | $180M | $192M | |
| Gross Profit Margin | -- | 23.05% | 18.97% | 21.45% | 21.15% | |
| R&D Expenses | -- | $24M | $24M | $26M | $20M | |
| Selling, General & Admin | -- | $100M | $104M | $108M | $105M | |
| Other Inc / (Exp) | -- | $5M | -$27M | -$11M | -- | |
| Operating Expenses | -- | $100M | $97M | $101M | $99M | |
| Operating Income | -- | $98M | $73M | $79M | $93M | |
| Net Interest Expenses | -- | $5M | $22M | $20M | $20M | |
| EBT. Incl. Unusual Items | -- | $121M | $30M | $53M | $19M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $32M | $31M | $22M | $6M | |
| Net Income to Company | -- | $89M | -$1M | $31M | $13M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | $89M | -$1M | $31M | $13M | |
| Basic EPS (Cont. Ops) | -- | $1.89 | -$0.02 | $0.72 | $0.34 | |
| Diluted EPS (Cont. Ops) | -- | $1.89 | -$0.02 | $0.70 | $0.33 | |
| Weighted Average Basic Share | -- | $47M | $47M | $43.1M | $38.7M | |
| Weighted Average Diluted Share | -- | $47M | $47M | $44.1M | $39.6M | |
| EBITDA | -- | $141M | $115M | $119M | $133M | |
| EBIT | -- | $98M | $73M | $79M | $93M | |
| Revenue (Reported) | -- | $859M | $896M | $839M | $908M | |
| Operating Income (Reported) | -- | $98M | $73M | $79M | $93M | |
| Operating Income (Adjusted) | -- | $98M | $73M | $79M | $93M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $3.5B | $3.5B | $3.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $2.8B | $2.7B | $2.7B | |
| Gross Profit | -- | $533M | $716M | $748M | $729M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | $107M | $110M | $107M | |
| Selling, General & Admin | -- | $301M | $412M | $431M | $442M | |
| Other Inc / (Exp) | -- | $3M | -$85M | -$34M | -- | |
| Operating Expenses | -- | -- | $405M | $429M | $416M | |
| Operating Income | -- | -- | $311M | $319M | $313M | |
| Net Interest Expenses | -- | $16M | $63M | $103M | $78M | |
| EBT. Incl. Unusual Items | -- | $253M | $238M | $208M | $185M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $94M | $101M | $95M | |
| Net Income to Company | -- | -- | $144M | $107M | $90M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | $144M | $107M | $90M | |
| Basic EPS (Cont. Ops) | -- | -- | $3.06 | $2.38 | $2.26 | |
| Diluted EPS (Cont. Ops) | -- | $3.98 | $3.06 | $2.34 | $2.22 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | $477M | $485M | $468M | |
| EBIT | -- | -- | $311M | $319M | $313M | |
| Revenue (Reported) | -- | -- | $3.5B | $3.5B | $3.4B | |
| Operating Income (Reported) | -- | -- | $311M | $319M | $313M | |
| Operating Income (Adjusted) | -- | -- | $311M | $319M | $313M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $2.5B | $2.6B | $2.6B | $2.6B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $2B | $2.1B | $2B | $2B | |
| Gross Profit | -- | $533M | $527M | $569M | $547M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $78M | $81M | $83M | $78M | |
| Selling, General & Admin | -- | $301M | $306M | $324M | $324M | |
| Other Inc / (Exp) | -- | $3M | -$86M | -$32M | $4M | |
| Operating Expenses | -- | $301M | $299M | $326M | $306M | |
| Operating Income | -- | $232M | $228M | $243M | $241M | |
| Net Interest Expenses | -- | $16M | $49M | $81M | $60M | |
| EBT. Incl. Unusual Items | -- | $253M | $144M | $146M | $144M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $66M | $75M | $72M | $59M | |
| Net Income to Company | -- | $187M | $69M | $74M | $85M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | $187M | $69M | $74M | $85M | |
| Basic EPS (Cont. Ops) | -- | $3.98 | $1.47 | $1.66 | $2.14 | |
| Diluted EPS (Cont. Ops) | -- | $3.98 | $1.47 | $1.63 | $2.10 | |
| Weighted Average Basic Share | -- | $141M | $141M | $134M | $118.9M | |
| Weighted Average Diluted Share | -- | $141M | $141M | $136.3M | $121.3M | |
| EBITDA | -- | $362M | $354M | $364M | $357M | |
| EBIT | -- | $232M | $228M | $243M | $241M | |
| Revenue (Reported) | -- | $2.5B | $2.6B | $2.6B | $2.6B | |
| Operating Income (Reported) | -- | $232M | $228M | $243M | $241M | |
| Operating Income (Adjusted) | -- | $232M | $228M | $243M | $241M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $259M | $251M | $365M | $484M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | $683M | $622M | $659M | $574M | |
| Inventory | -- | $417M | $459M | $487M | $444M | |
| Prepaid Expenses | -- | $22M | $17M | $40M | $79M | |
| Other Current Assets | -- | $14M | $20M | $18M | $17M | |
| Total Current Assets | -- | $1.6B | $1.6B | $1.9B | $1.8B | |
| Property Plant And Equipment | -- | $1.1B | $1B | $984M | $897M | |
| Long-Term Investments | -- | $98M | $117M | $115M | $111M | |
| Goodwill | -- | $496M | $490M | $499M | $471M | |
| Other Intangibles | -- | $470M | $432M | $417M | $374M | |
| Other Long-Term Assets | -- | $46M | $25M | $38M | $31M | |
| Total Assets | -- | $4.2B | $4.1B | $4B | $3.8B | |
| Accounts Payable | -- | $455M | $500M | $639M | $522M | |
| Accrued Expenses | -- | $81M | $94M | $118M | $143M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $89M | $25M | |
| Current Portion Of Capital Lease Obligations | -- | $19M | $18M | $17M | $17M | |
| Other Current Liabilities | -- | $191M | $165M | $187M | $175M | |
| Total Current Liabilities | -- | $1.2B | $1.2B | $1.1B | $969M | |
| Long-Term Debt | -- | $1B | $1B | $758M | $1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $2.5B | $2.4B | $2.1B | $2.2B | |
| Common Stock | -- | $1.6B | $1.7B | $1M | $1M | |
| Other Common Equity Adj | -- | $62M | -$88M | -$131M | -$217M | |
| Common Equity | -- | $1.7B | $1.6B | $1.9B | $1.6B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | $3M | -- | -- | -- | |
| Total Equity | -- | $1.7B | $1.6B | $1.9B | $1.6B | |
| Total Liabilities and Equity | -- | $4.2B | $4.1B | $4B | $3.8B | |
| Cash and Short Terms | -- | $259M | $251M | $365M | $484M | |
| Total Debt | -- | $1.1B | $1.1B | $772M | $1B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | $367M | $477M | $349M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | $1.2B | $634M | $673M | |
| Inventory | -- | -- | $529M | $486M | $523M | |
| Prepaid Expenses | -- | -- | $23M | $77M | $123M | |
| Other Current Assets | -- | -- | $18M | $16M | -- | |
| Total Current Assets | -- | -- | $2.1B | $2B | $1.9B | |
| Property Plant And Equipment | -- | -- | $953M | $937M | $916M | |
| Long-Term Investments | -- | -- | $130M | $125M | $154M | |
| Goodwill | -- | -- | $486M | $496M | -- | |
| Other Intangibles | -- | -- | $411M | $397M | -- | |
| Other Long-Term Assets | -- | -- | $29M | $36M | -- | |
| Total Assets | -- | -- | $4.2B | $4B | $4B | |
| Accounts Payable | -- | -- | $817M | $588M | $627M | |
| Accrued Expenses | -- | -- | $105M | $137M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | $87M | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $17M | $17M | -- | |
| Other Current Liabilities | -- | -- | $199M | $202M | -- | |
| Total Current Liabilities | -- | -- | $1.3B | $1B | $1.1B | |
| Long-Term Debt | -- | -- | $764M | $1B | $1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $2.3B | $2.3B | $2.4B | |
| Common Stock | -- | -- | $1M | $1M | $1M | |
| Other Common Equity Adj | -- | -- | -$122M | -$115M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | $1.9B | $1.7B | $1.6B | |
| Total Liabilities and Equity | -- | -- | $4.2B | $4B | $4B | |
| Cash and Short Terms | -- | -- | $367M | $477M | $349M | |
| Total Debt | -- | -- | $851M | $1B | $1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$124M | $153M | $262M | $102M | $79M | |
| Depreciation & Amoritzation | $62M | $204M | $170M | $171M | $160M | |
| Stock-Based Compensation | $3M | $11M | $11M | $10M | $14M | |
| Change in Accounts Receivable | -$37M | $16M | -$103M | $79M | $149M | |
| Change in Inventories | $4M | -$84M | -$60M | -$4M | $23M | |
| Cash From Operations | -$97M | $147M | $303M | $250M | $308M | |
| Capital Expenditures | $54M | $146M | $107M | $150M | $105M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $369M | -$140M | -$105M | -$150M | -$101M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | $23M | $44M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $95M | $126M | $140M | $819M | $975M | |
| Long-Term Debt Repaid | -$112M | -$178M | -$118M | -$732M | -$797M | |
| Repurchase of Common Stock | -- | -- | -- | $24M | $212M | |
| Other Financing Activities | $19M | $8M | -$207M | -$19M | -$15M | |
| Cash From Financing | $2M | -$44M | -$185M | $20M | -$96M | |
| Beginning Cash (CF) | $4M | $259M | $251M | $365M | $484M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $288M | -$33M | -$8M | $114M | $119M | |
| Ending Cash (CF) | $292M | $230M | $222M | $473M | $611M | |
| Levered Free Cash Flow | -$151M | $1M | $196M | $100M | $203M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $89M | -$1M | $31M | $13M | |
| Depreciation & Amoritzation | -- | $43M | $42M | $40M | $40M | |
| Stock-Based Compensation | -- | $2M | $3M | $3M | $5M | |
| Change in Accounts Receivable | -- | -$87M | -$59M | $61M | $14M | |
| Change in Inventories | -- | -$4M | -$8M | -$2M | -$16M | |
| Cash From Operations | -- | $45M | $155M | $95M | $119M | |
| Capital Expenditures | -- | $26M | $37M | $25M | $26M | |
| Cash Acquisitions | -- | -- | -- | -- | $9M | |
| Cash From Investing | -- | -$22M | -$37M | -$25M | -$35M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | $12M | $10M | $11M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $9M | $783M | $450M | -- | |
| Long-Term Debt Repaid | -- | $7M | -$635M | -$294M | -- | |
| Repurchase of Common Stock | -- | -- | $9M | $75M | $30M | |
| Other Financing Activities | -- | -$16M | -$77M | -$6M | -- | |
| Cash From Financing | -- | -- | $50M | $65M | -$76M | |
| Beginning Cash (CF) | -- | $169M | $367M | $477M | $349M | |
| Foreign Exchange Rate Adjustment | -- | -$22M | -$14M | $3M | -$6M | |
| Additions / Reductions | -- | $1M | $154M | $138M | $2M | |
| Ending Cash (CF) | -- | $170M | $507M | $618M | $345M | |
| Levered Free Cash Flow | -- | $19M | $118M | $70M | $93M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $144M | $107M | $90M | |
| Depreciation & Amoritzation | -- | -- | $166M | $166M | $155M | |
| Stock-Based Compensation | -- | $7M | $11M | $14M | $16M | |
| Change in Accounts Receivable | -- | -- | -$77M | $282M | $44M | |
| Change in Inventories | -- | -- | -$45M | $58M | -$23M | |
| Cash From Operations | -- | -- | $369M | $297M | $289M | |
| Capital Expenditures | -- | $86M | $138M | $118M | $115M | |
| Cash Acquisitions | -- | -- | -- | -- | $9M | |
| Cash From Investing | -- | -- | -$142M | -$117M | -$120M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | $12M | $44M | $43M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $930M | $975M | -- | |
| Long-Term Debt Repaid | -- | -- | -$734M | -$800M | -- | |
| Repurchase of Common Stock | -- | -- | $9M | $203M | $196M | |
| Other Financing Activities | -- | -- | -$207M | -- | -- | |
| Cash From Financing | -- | -- | -$32M | -$91M | -$280M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | $197M | $110M | -$128M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | $231M | $179M | $174M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $187M | $69M | $74M | $85M | |
| Depreciation & Amoritzation | -- | $130M | $126M | $121M | $116M | |
| Stock-Based Compensation | -- | $7M | $7M | $11M | $13M | |
| Change in Accounts Receivable | -- | -$149M | -$123M | $80M | -$25M | |
| Change in Inventories | -- | -$75M | -$60M | $2M | -$44M | |
| Cash From Operations | -- | $122M | $188M | $235M | $216M | |
| Capital Expenditures | -- | $86M | $117M | $85M | $95M | |
| Cash Acquisitions | -- | -- | -- | -- | $9M | |
| Cash From Investing | -- | -$80M | -$117M | -$84M | -$103M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | $12M | $33M | $32M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $29M | $819M | $975M | -- | |
| Long-Term Debt Repaid | -- | -$113M | -$729M | -$797M | -- | |
| Repurchase of Common Stock | -- | -- | $9M | $188M | $172M | |
| Other Financing Activities | -- | -$19M | -$19M | -$15M | -- | |
| Cash From Financing | -- | -$103M | $50M | -$61M | -$245M | |
| Beginning Cash (CF) | -- | $621M | $761M | $1.1B | $1.1B | |
| Foreign Exchange Rate Adjustment | -- | -$28M | -$5M | $22M | -$3M | |
| Additions / Reductions | -- | -$89M | $116M | $112M | -$135M | |
| Ending Cash (CF) | -- | $532M | $872M | $1.3B | $931M | |
| Levered Free Cash Flow | -- | $36M | $71M | $150M | $121M | |
Get PHIN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PHIN
Sector
P/E ratio
31.30x
17.35x
PEG ratio
0.34x
0.11x
P/B ratio
1.68x
1.34x
Price / LTM sales
0.83x
0.59x
Growth Metrics
PHIN
Sector
Revenue growth
8.22%
3.35%
Earnings growth
-53.3%
--
Revenue (5-year growth)
--
3.16%
Earnings forecast
$1.15
$0.25
Profitability
PHIN
Sector
Profitability FY 2024
$726M
$293.9M
Return on invested capital
3.4%
3.41%
Return on assets
2.32%
2.25%
Return on equity
5.61%
5.88%
Earnings Date
Last Earnings Date
Oct
28
Next Earnings Date
Feb
12
Estimated Next Earnings Date
Jan
27
Balance Sheet
PHIN
Sector
Total cash
$349M
$128.4M
Short term investments
--
$40.6M
Total assets
$3.8B
$1.1B
Long term debt
$1B
$33.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
75
AGX alert for Jan 17
Argan, Inc. [AGX] is up 16.4% over the past day.
Buy
80
ASTS alert for Jan 17
AST Spacemobile, Inc. [ASTS] is up 14.32% over the past day.
Buy
84
IREN alert for Jan 17
IREN Ltd. [IREN] is up 11.35% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
